Zomedica Corp [AMEX: ZOM] stock went on a downward path that fall over -0.31% on Thursday, amounting to a one-week price decrease of less than -1.14%.
Over the last 12 months, ZOM stock dropped by -19.70%. The one-year Zomedica Corp stock forecast points to a potential upside of 70.45. The average equity rating for ZOM stock is currently 3.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $127.39 million, with 979.95 million shares outstanding and 962.51 million shares in the current float. Compared to the average trading volume of 3.02M shares, ZOM stock reached a trading volume of 3475259 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Zomedica Corp [ZOM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $0.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZOM stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Dawson James have made an estimate for Zomedica Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 06, 2023.
The Average True Range (ATR) for Zomedica Corp is set at 0.01, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 4.88. The Price to Book ratio for the last quarter was 0.61, with the Price to Cash per share for the same quarter was set at 0.08.
ZOM Stock Performance Analysis:
Zomedica Corp [ZOM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.14. With this latest performance, ZOM shares gained by 5.52% in over the last four-week period, additionally sinking by -8.77% over the last 6 months – not to mention a drop of -19.70% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 46.87, with the RSI for the last a single of trading hit 47.37, and the three-weeks RSI is set at 46.07 for Zomedica Corp [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.1369, while it was recorded at 0.1320 for the last single week of trading, and 0.1462 for the last 200 days.
Insight into Zomedica Corp Fundamentals:
Zomedica Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.68 and a Current Ratio set at 11.39.
Zomedica Corp [ZOM] Institutonal Ownership Details
There are presently around $8.62%, or 8.78%% of ZOM stock, in the hands of institutional investors. The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 29.93 million shares, which is approximately 3.054%. BLACKROCK INC., holding 26.21 million shares of the stock with an approximate value of $$334.65 million in ZOM stocks shares; and BLACKROCK INC., currently with $$330.43 million in ZOM stock with ownership which is approximately 2.6405%.
